Intra-Cellular Therapies, Inc.
ITCIDelisted Apr 2, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001567514
Intra-Cellular Therapies, Inc. was delisted on Apr 2, 2025; its insiders filed their last Form 4 on Apr 2, 2025; 395 institutions reported holding it in 13F filings for Q1 2025, worth $13.6B in total; Soros Fund Management was the only superinvestor holding it.
Q4 2023 vs. Q3 2023
How the institutions holding Intra-Cellular Therapies, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Of which not filed for Q4 2023 | Q4 2023 | Change |
|---|---|---|---|---|
| Holders | 294 | 5 | 335 | +46 |
| Shares | 87.2M | 339.9K | 89.6M | +2.73M (+3.1%) |
| Value | $4.54B | $17.7M | $6.42B | +$1.89B (+41.7%) |
5 institutions that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (73)
Institutions that held Intra-Cellular Therapies, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
Sold out (27)
Institutions that held Intra-Cellular Therapies, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
Not filed for Q4 2023 yet (5)
Institutions that held Intra-Cellular Therapies, Inc. at the end of Q3 2023 and haven't filed a 13F for Q4 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| International Biotechnology Trust PLC | 317,856 | $16.5M |
| First Republic Investment Management, Inc. | 14,484 | $754.5K |
| Virginia Retirement Systems Et Al | 4,000 | $208.4K |
| Cyrus J. Lawrence, LLC | 3,550 | $184.0K |
| Steward Financial Group LLC | 38 | $1.00K |